Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

User discusses using C60 serum with microneedling at 1.75mm and asks if it's safe. Current routine includes daily Pyril on temples, weekly microneedling, and C60 serum on non-Pyril days.

A user successfully regrew hair using finasteride, minoxidil, ketoconazole shampoo, biotin supplements, and rosemary mint oil, despite initial side effects. They highlighted the need for commitment, a healthy lifestyle, and being a "hyper responder" to treatments.

The user shared five months of progress using oral finasteride, topical minoxidil, and supplements like biotin, zinc, omega-3, and collagen. They noted encouraging results, while others suggested trying oral minoxidil or microneedling for potentially better outcomes.

A 26-year-old male shared progress pictures after 4 months of using a compounded spray with minoxidil, finasteride, and tretinoin, along with dermastamping and ketoconazole shampoo, noting minimal visible change but expecting results soon. Users commented on noticeable progress from bald to having hair and inquired about the treatment composition.

The user shared their 6-month progress using finasteride, minoxidil, and creatine monohydrate daily, along with a specific shampoo routine. They reported positive results without experiencing a shedding phase and did not use dermarolling.

AMP-303 and AMP-601 are new hair loss treatments targeting dermal papilla cells, with AMP-303 showing early efficacy in transitioning vellus hairs to terminal hairs after one injection. Further clinical trials are planned, and these treatments are seen as promising due to their biologic approach and less frequent application compared to daily treatments.

PP405, developed by Pelage Pharmaceuticals, can reactivate dormant hair follicle stem cells and increase hair growth by 20% in eight weeks, unlike minoxidil or finasteride. However, skepticism remains about its effectiveness and availability, with concerns about funding and the timeline for broader access.

People are discussing their reactions if PP405 fails in phase 3 trials, with some expressing skepticism and others holding onto hope for future treatments like GT20029 and Breezula. Many mention continuing with existing treatments like minoxidil and finasteride, while others express disappointment and consider alternative solutions.

The user shared their 4-month progress using oral finasteride and topical minoxidil, with a specific application routine. They adjust the minoxidil application to manage costs, applying it daily with variations in quantity and additional tretinoin on certain days.

A user shared a beard growth protocol involving hydration toner, azelaic acid, tretinoin, moisturizer, 5% topical minoxidil, and SPF 30+ sunscreen. The regimen spans a year to a year and a half, with specific application schedules for different phases.

Hair follicle stem cells remain in bald individuals, but progenitor cells do not, raising questions about hair regrowth claims by Pelage. PP405 is discussed as a potential treatment, with skepticism about its effectiveness compared to existing treatments like Minoxidil and Finasteride.

A 32-year-old shares 2-month progress using oral finasteride, topical minoxidil, and weekly derma stamping for hair loss, noting early improvements and no side effects. Encouragement is given for continued progress.

The user shared their 18-month hair transplant progress, using oral Minoxidil and Dutasteride since December 2024. They noted significant improvement between months 6-9 and emphasized the importance of continuing DHT blockers to maintain native hair.

The conversation discusses hair regrowth progress using topical dutasteride with cetirizine, laser therapy, and growth serum. The user observes miniaturized, vellus hairs on the scalp.

Clascoterone shows promising results for hair regrowth in men with androgenetic alopecia, with potential FDA approval by 2026. It acts as a topical androgen receptor blocker, offering a new treatment option with minimal side effects compared to existing treatments like finasteride.

A user shared their positive experience with a hair loss treatment using a compounded topical solution of Minoxidil, finasteride, tretinoin, and caffeine, along with ketoconazole shampoo, pumpkin seed oil, zinc, biotin, and microneedling. They reported noticeable hair regrowth and no negative side effects.

The user shared progress after 26 months using finasteride and minoxidil, noting a plateau after 18 months but expressing satisfaction with the results. They used a HIMS min/fin spray and finasteride pills, and considered adding tretinoin foam to enhance minoxidil effectiveness.

PP405 is a promising new treatment for hair loss. It performs three actions in one, potentially offering a cure.

Clascoterone is a topical treatment for androgenetic alopecia, showing modest to moderate hair regrowth, and may be available by 2027-2028. It is considered safer than finasteride, with discussions on its effectiveness compared to RU58841 and pyrilutamide.

The conversation discusses the anticipation of clascoterone scalp treatment results for hair loss, with concerns about its availability and high cost. Users express hope for positive outcomes and affordable access.

The user shared their experience with CB-03-01 (Breezula/Clascoterone) for hair loss, noting reduced shedding and improved hair appearance but experiencing significant sleep disturbances and low energy due to HPA axis suppression. They decided to stop using it due to these side effects and are waiting for GT20029 as an alternative.

A 20-year-old male is using ketoconazole shampoo, oral minoxidil, dutasteride, and topical minoxidil with tretinoin for hair loss. He seeks feedback on progress after one month, but is advised to be patient.

A user shared their 15-month hair regrowth progress using finasteride, minoxidil, biotin, increased protein intake, and derma rolling. They also improved their lifestyle by working out, quitting smoking, drinking less, and getting better sleep.

The conversation is about a person recovering from drug-induced malnourishment, regaining hair growth, and improving overall health. They attribute their progress to stopping drug use, focusing on nutrition, and possibly using hormone replacement therapy (HRT).

Copper peptides GHK-Cu and AHK-Cu are discussed for hair loss treatment, with questions about their effectiveness and application methods. One user suggests sticking to traditional treatments like Minoxidil and Finasteride, as they didn't notice significant results with copper peptides.

A 28-year-old has been using oral dutasteride 0.5 mg, topical minoxidil 5%, and Cafune shampoo for 104 days with positive results and is considering adding microneedling. No side effects from dutasteride have been reported.

Breezula's phase 3 results are expected in July or August, with commercialization possibly in two years. There are concerns about delays and effectiveness, and the cost may be high.

PP405 shows significantly better early-stage hair regrowth results compared to minoxidil and finasteride, with 31% of users experiencing over 20% density increase in 4–8 weeks. Minoxidil and finasteride show minimal or no visible regrowth in the same timeframe.

Pelage Pharmaceuticals received $120 million in Series B funding for hair loss treatment development. The conversation expresses excitement and anticipation for the release and effectiveness of the treatment.

A user shared their two-year journey using minoxidil and finasteride, with additional use of dutasteride and a derma pen, noting some progress but a plateau in results. They are considering adding more treatments or a hair transplant to improve their hair further.